| 2026-03-28 22:07 | UU:SKTCF | | News Release200 | Skychain Technologies Inc. Provides Update on Financial Position, Asset Status, and Ongoing Transition Issues |
| 2026-03-28 20:20 | UU:ELEK | | News Release200 | Where Speed Meets Opportunity - a New Era in Electric Mobility Begins |
| 2026-03-28 16:45 | UU:AMGN | | News Release200 | REPATHA(TM) CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS |
| 2026-03-28 15:15 | UU:LLY | | News Release200 | Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity |
| 2026-03-28 15:00 | UU:TAK | | News Release200 | Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care |
| 2026-03-28 15:00 | UU:ROIV | | News Release200 | New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis |
| 2026-03-28 15:00 | UU:MLTX | | News Release200 | MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting |
| 2026-03-28 15:00 | UU:INCY | | News Release200 | Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting |
| 2026-03-28 15:00 | UU:BIIB | | News Release200 | Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity |
| 2026-03-28 14:45 | UU:CORT | | News Release200 | Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session |
| 2026-03-28 13:30 | UU:ALMS | | News Release200 | Alumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis |
| 2026-03-28 12:36 | UU:NKTR | | News Release200 | Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting |
| 2026-03-28 11:00 | UU:KYMR | | News Release200 | Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting |
| 2026-03-28 11:00 | UU:ARQT | | News Release200 | Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting |
| 2026-03-28 10:55 | UU:BSX | | News Release200 | CHAMPION-AF study of the WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints |
| 2026-03-28 10:38 | UU:BSX | | News Release200 | HI-PEITHO trial demonstrates Boston Scientific EKOS(TM) Endovascular System is superior to standard of care for treatment of acute pulmonary embolism |
| 2026-03-28 10:30 | UU:ARWR | | News Release200 | Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology's 75th Annual Scientific Session and Expo |
| 2026-03-28 10:05 | UU:PTGX | | News Release200 | Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting |
| 2026-03-28 10:00 | UU:JNJ | | News Release200 | ICOTYDE(TM) (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis |
| 2026-03-28 07:00 | UU:V | | News Release200 | Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S. |
| 2026-03-28 07:00 | UU:V | | News Release200 | Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S. |
| 2026-03-28 07:00 | UU:BMY | | News Release200 | Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy(TM) (xanomeline and trospium chloride) |
| 2026-03-28 07:00 | UU:BAC | | News Release200 | Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S. |
| 2026-03-28 07:00 | UU:BAC | | News Release200 | Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026(TM) Host City in the U.S. |
| 2026-03-28 06:40 | UU:RKLB | | News Release200 | Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency |